← Open Payments lookup

CHELSEA KIZER: Open Payments

NPI 1518588706 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,217 in 58 payments from 15 companies in 2025. Trend: 2023 $1,735 · 2024 $1,217 · 2025 $1,217

Food & beverage: $1,127Education: $90
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$271
GlaxoSmithKline, LLC.24$218
GENZYME CORPORATION3$145
Boehringer Ingelheim Pharmaceuticals, Inc.6$139
Actelion Pharmaceuticals US, Inc.2$119
Merck Sharp & Dohme LLC4$93
Amgen Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.1$33
Vifor Pharma, Inc.1$30
Viatris Specialty LLC1$29

Products named: FASENRA, DUPIXENT, TRELEGY ELLIPTA, OPSUMIT, NUCALA, OFEV, JASCAYD, WINREVAIR.

Industry payments across IN — which companies pay providers there.